Cencora appointed Mark Durcan as Chairman of the Board, while Steven H. Collis served as CEO and Chairman.
3 reports, 2 independent
Updated Aug 28
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cencora appointed Mark Durcan as Chairman of the Board, while Steven H. Collis served as CEO and Chairman.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Cencora leadership changes with Mark Durcan appointed Chairman.1 source
Collis, former Cencora CEO, joins Elevance board for pharmacy services.1 source
- Steven H. Collis sold shares of Cencora on June 26, 2025.
Keep exploring
The entities involved
-
Cencora
US drug wholesale company company
-
Steven H. Collis
American businessman, the chairman, president and chief executive officer (CEO) of AmerisourceBergen
Nothing else this week.
-
Mark Durcan
American businessman
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireCencora Appoints Mark Durcan as Chairman of Its Board of Directors CONSHOHOCKEN, Pa., August 27, 2025--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has appoi
- Healthcare DiveElevance names former Cencora CEO to board This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Elevanc
- Unknown outlet